Pituitary adenomas are slowly progressive and usually benign type of tumors which may induce a poor quality of life of patients due to progressive loss of vision over time by compression of optic nerves, cavernous sinus, optic chiasm. Its therapy generally involves differential diagnosis with an MRI of Brain and surgical option with radiation therapy. Here with we present a case of 48 year old women who had undergone microscopic transnasal transphenorbital excision of tumor two years ago of pituitary macroadenoma. She was not on any chemotherapy which led to a recurrence of her tumor. Presently her MRI scan and histopathologic reports confirms the diagnosis of Pituitary macroadenoma which was effectively treated surgically and put up on Dihydroartemisnin, a derivative of Artemether which has similar cytotoxic properties as that of artemether.
INTRODUCTION
About 10% of the intracranial tumors are due to Pituitary macro adenomas which are most common in the sellar region. It cause compression of the optic nerves, cavernous sinus, optic chaism, due to which severe but slow impact on vision damage occurs [Chen X, et al.(2011) ]. On the basis of their they are classified as macroadenoma if it is >1cm and microadenomas when the diameter is <10mm. some patients experience with a dumbbell like extension of pituitary tumor into the diaphragm through small openings by pituitary stalk [Inderjit IK, et al.(2001) ]. It is invasive when the extension is into the suprasellar cistern by stretching and fenestrating the diaphragm sellae and arachnoids layer [Choudhary V & Bano S(2011) ]. Pituitary adenomas are always benign without any malignant potential. Pituitary lesions are divided into nonsecretory and secretory tumors of the gland, along with parasellar and intrasellar tumors [Johnson MD, et al(2003) ].
Case Report:
A 48 year old female patient was presented to the hospital with headache of gradual onset which further progressed severely within 3 months duration, progressive loss of vision in the right eye for the past 3 months. She had a past medical history of pituitary adenoma cleft pterimal; craniotomy and subtotal excision of space occupying lesion done two years back. She was a known case of hypothyroidism on therapy with T. Levothyroxine for the past 4 years. She had a history of complete loss of vision of the left eye past 2 years, amenorrhea for the past 9 years, and progressive increase in weight past 6 years. There was no history or complaints of disturbance in smell, altered sensation to fall, altered taste sensation, regurgitation, aspiration of liquids, rolling over of tongue, weakness of limbs, sensory disturbance over any part of the body, involuntary movements, seizures or imbalance while walking. Her MRI of brain report suggested a well defined dumbbell shaped T2 heterointense and T1 isointense mass lesion with T1 hyperintense foci along the posterior aspect noted on sella and supra sellar region with expansion of sella. Pituitary gland not visualized separately, the lesions measures 4.2 cm (cranio caudal) x 2.4cm (anteroposterior) x 2.6cm (transverse) with cystic areas and causes compression of optic chaisma and displacing bilateral internal carotid artery without encasement. (Table 1) . Her blood cortisol levels were around 6.02 -18.4 µg/dl (6-10 AM) and 2.68-10.5
µg/dl (4-8PM along with radiotherapy has shown a better quality of life in about 86% of patients [Yildiz F, et al(1999) ]. One such therapy with Artemether, an anti-malarial drug has shown improving rates in the prevention of recurrence of adenomas. The drug produces free radicals that cause macromolecular damage and cell death [Park P, et al(2004) ]. Cancer cells are more susceptible to cytotoxic effects of artemether due to the higher influx of iron via transferrin receptor mechanism. It kills cancer cells by apoptosis which is a preferable mode of cancer cell death [Dekkers OM, et al(2006) ]. Inspite of poor quality of life with surgical therapy alone and increased incidence for reoccurrence, it is better preferred to add upon a drug therapy for minimal side effects and better therapy [Sassolas G, et al(1993) ]. In this patient dihydroartemisnin 120mg was prescribed for betterment of the condition which showed improvement in her MRI reports there after. The mechanism of dihydroartemisnin was found to b the same as that of artemether with cytotoxic activity. MRI is one among the best imaging techniques in the confirmation of pituitary adenomas. Detection and characterization of adenomas is done finely with contrast MRI using Gadolinium [Zhang F, et al(1992) ]. Inaccurate delineation of microadenomas has led to the emergence of dynamic imaging and in the differentiation of recurrent or residual adenoma from post-operative tissues. The atmost advancement in pituitary imaging is the use of intraoperative and its ultrasonography at the time of endoscopic pituitary surgery. Better visualizing of parasellar and intrasellar anatomy is obtained for clear resection of tumors [Lai H & Singh NP(1995) ].
CONCLUSION
Therapy providing the minimal side effects and improving quality of life is generally indicated to the patients. Surgical therapy alone with radiation does not promise a good result on the quality of life due to the side effects faced and the increased recurrence rates. Thus it is always better to add upon a chemotherapeutic agent to provide a better quality of life to patients and to avoid the recurrence rates on adenomas.
